Association of gene polymorphisms of the reninangiotensin system and endothelial dysfunction with development and severity of portal hypertension in patients with chronic hepatitis C
-
Published:2016-09-29
Issue:6
Volume:44
Page:698-712
-
ISSN:2587-9294
-
Container-title:Almanac of Clinical Medicine
-
language:
-
Short-container-title:Alʹm. klin. med.
Author:
Taratina O. V.1, Samokhodskaya L. M.2, Krasnova T. N.2, Mukhin N. A.2
Affiliation:
1. Moscow Regional Research and Clinical Institute, Moscow 2. Lomonosov Moscow State University, Moscow
Publisher
Moscow Regional Research and Clinical Institute (MONIKI)
Reference36 articles.
1. World Health Organization. Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. Updated version. April 2016. Available from: http://www.who.int/hepatitis/publications/hepatitis-c-guide-lines-2016/en/. 2. European Association for Study of Liver. EASL Recommendations on Treatment of Hepatitis C 2015. J Hepatol. 2015;63(1):199-236. doi: 10.1016/j.jhep.2015.03.025. 3. AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis C. 2016. Available from: http://hcvguidelines.org/print-pdf/84. 4. Hatzakis A, Chulanov V, Gadano AC, Bergin C, Ben-Ari Z, Mossong J, Schreter I, Baatarkhuu O, Acharya S, Aho I, Anand AC, Andersson MI, Ar-endt V, Arkkila P, Barclay K, Bessone F, Blach S, Blokhina N, Brunton CR, Choudhuri G, Cisne-ros L, Croes EA, Dahgwahdorj YA, Dalgard O, Daruich JR, Dashdorj NR, Davaadorj D, de Knegt RJ, de Vree M, Estes C, Flisiak R, Gane E, Gower E, Halota W, Henderson C, Hoffmann P, Hornell J, Houlihan D, Hrusovsky S, Jarcuska P, Kershenobich D, Kostrzewska K, Kristian P, Leshno M, Lurie Y, Mahomed A, Mamonova N, Mendez-Sanchez N, Norris S, Nurmukhametova E, Nymadawa P, Oltman M, Oyunbileg J, Oyunsuren T, Papatheodoridis G, Pimenov N, Prabdial-Sing N, Prins M, Radke S, Rakhmanova A, Razavi-Shearer K, Reesink HW, Ridruejo E, Safadi R, Sagalova O, Sanchez Avi-la JF, Sanduijav R, Saraswat V, Seguin-Devaux C, Shah SR, Shestakova I, Shevaldin A, Shibolet O, Silva MO, Sokolov S, Sonderup M, Souliotis K, Spearman CW, Staub T, Stedman C, Strebko-va EA, Struck D, Sypsa V, Tomasiewicz K, Un-dram L, van der Meer AJ, van Santen D, Veld-huijzen I, Villamil FG, Willemse S, Zuckerman E, Zuure FR, Puri P, Razavi H. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm -volume 2. J Viral Hepat. 2015;22 Suppl 1:26-45. doi: 10.1111/jvh.12351. 5. Yushchuk ND, Znoyko OO, Yakushechkina NA, Dudina KR, Shut'ko SA, Kozina AN, Safiul-lina NKh, Fedoseeva NV, Belyy PA, Lugov-skikh EA, Rakhmanova AG, Khubutiya MSh, Pimenov NN, Chulanov VP, Chesnokov EV, Ogarev VV. Otsenka sotsial'no-ekonomichesk-ogo bremeni gepatita S v Rossiyskoy Federatsii [Assessment of the Socio-Economic Burden of Hepatitis C in the Russian Federation]. Epide-miologiya i vaktsinoprofilaktika [Epidemiology & Vaccinal Prevention]. 2013;69(2):18-33 (in Russian).
|
|